Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation (2461)

Yves Dauvilliers; Michael Thorpy; Thomas Roth; Russell Rosenberg; Bruce Corser; Colin Shapiro; Akinyemi Ajayi; Jordan Dubow; David Seiden; Clete Kushida

doi:10.1212/WNL.96.15_supplement.2461

Retour

Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation (2461)

Article de revue

Avec comité de lecture

Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation (2461)

Yves Dauvilliers, Michael Thorpy, Thomas Roth, Russell Rosenberg, Bruce Corser, Colin Shapiro, Akinyemi Ajayi, Jordan Dubow, David Seiden et Clete Kushida

Neurology, Vol.96(15_supplement)

13/04/2021

DOI: https://doi.org/10.1212/WNL.96.15_supplement.2461

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Titre: Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation (2461)
Créateurs - sans rôle: Yves Dauvilliers - Hopital Gui De Chaulliac
Michael Thorpy - Montefiore Medical Center
Thomas Roth - Henry Ford Hospital
Russell Rosenberg - NeuroTrials Research
Bruce Corser - Sleep Management Institute
Colin Shapiro - International Sleep Clinic
Akinyemi Ajayi - Florida Pediatric Research Institute
Jordan Dubow - Avadel Pharmaceuticals
David Seiden - Avadel Pharmaceuticals
Clete Kushida - Stanford Sleep Medicine Center
Détails de publication: Neurology, Vol.96(15_supplement)
Identifiants: 99139823809311
Unité académique: Institut des Neurosciences de Montpellier - INM
Langue: English
Type de ressource: Journal article